U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022321

Expand all

EMBEDA (MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE)
20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Proprietary Name: EMBEDA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022321
Product Number: 001
Approval Date: Aug 13, 2009
Applicant Holder Full Name: ALPHARMA PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
EMBEDA (MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE)
30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Proprietary Name: EMBEDA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022321
Product Number: 002
Approval Date: Aug 13, 2009
Applicant Holder Full Name: ALPHARMA PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
EMBEDA (MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE)
50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Proprietary Name: EMBEDA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022321
Product Number: 003
Approval Date: Aug 13, 2009
Applicant Holder Full Name: ALPHARMA PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
EMBEDA (MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE)
60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Proprietary Name: EMBEDA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022321
Product Number: 004
Approval Date: Aug 13, 2009
Applicant Holder Full Name: ALPHARMA PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
EMBEDA (MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE)
80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Proprietary Name: EMBEDA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022321
Product Number: 005
Approval Date: Aug 13, 2009
Applicant Holder Full Name: ALPHARMA PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
EMBEDA (MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE)
100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Proprietary Name: EMBEDA
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022321
Product Number: 006
Approval Date: Aug 13, 2009
Applicant Holder Full Name: ALPHARMA PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top